ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) shares traded down 4.2% during trading on Wednesday . The stock traded as low as $0.34 and last traded at $0.36. 357,431 shares were traded during mid-day trading, an increase of 1,658% from the average session volume of 20,327 shares. The stock had previously closed at $0.38.
ImmunoPrecise Antibodies Stock Performance
The firm’s 50-day simple moving average is $0.42 and its two-hundred day simple moving average is $0.47.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Recommended Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to Choose Top Rated Stocks
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
